RE:RE:CPTR not RTO target for MedMenKeep in mind we own MedMen shares at a $1B valuation and MedMen will most likely fetch a $2B+ valuation on this round thus making our initiail investment turn into nearly $60M.
I would rather see CPTR contunue to acquire their own dispensaries and partner with MedMen on certain locations.
If you do the math based on their 2 locations edging towards $40M in revenue per year, what would that number look like at 20+ locations?
Furthermore, with their most recent acqusion having the license and roadmap to build out a 500,000 sqf facility in California that has not even been priced into the potential yet, I see a multibagger stock just based on these elements. Who knows what other acquisitions could also be in the pipeline???
You need to compare CPTR's current revenues to Aphria, Aurora, Organigram, Canopy and you can start to see the big picture of where this can potentially go. None of these companies had anywere near these revenues when they started to run up and some still dont except for the 700 pound gorrila Canopy
I agree, they need to sell out all of their other assets asap and use that cash to buy more dispensaries that are cash flow positive.